Compounds > aspirin

aspirin and mk-0524

aspirin has been researched along with mk-0524 in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Crumley, TM; De Lepeleire, I; Gottesdiener, K; Lai, E; Liu, F; Michiels, N; O'Neill, G; Vets, E; Wagner, JA; Wenning, LA	1
Atiee, GJ; Dishy, V; Ebel, DL; Lai, E; Liu, F; Paolini, JF; Reilley, S; Royalty, J; Wagner, JA	1
Arora, R; Sood, A	1
Dallob, A; De Hoon, JN; De Lepeleire, I; Dishy, V; Johnson-Levonas, AO; Kraft, WK; Lai, E; Luk, JM; Luo, WL; Radziszewski, W; Ratcliffe, L; Schwartz, JI; Van Hecken, A; Wagner, JA	1
De Kam, PJ; Lai, E; Luo, WL; Radziszewski, W; Ratcliffe, L; Royalty, J; Sisk, CM; Wagner, JA; Wenning, L	1

Reviews

1 review(s) available for aspirin and mk-0524

Article	Year
Mechanisms of flushing due to niacin and abolition of these effects. Journal of clinical hypertension (Greenwich, Conn.), 2009, Volume: 11, Issue:11 Topics: Aspirin; Dose-Response Relationship, Drug; Dyslipidemias; Humans; Hypolipidemic Agents; Indoles; Niacin; Pruritus	2009

Trials

4 trial(s) available for aspirin and mk-0524

Article	Year
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1. Clinical pharmacology and therapeutics, 2007, Volume: 81, Issue:6 Topics: Adolescent; Adult; Aspirin; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Indoles; Male; Middle Aged; Niacin; Receptors, Immunologic; Receptors, Prostaglandin; Regional Blood Flow; Skin; Vasodilation; Vasodilator Agents	2007
Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms. Journal of clinical pharmacology, 2009, Volume: 49, Issue:4 Topics: Administration, Oral; Adult; Aged; Aspirin; Cross-Over Studies; Cyclooxygenase Inhibitors; Delayed-Action Preparations; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Flushing; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Niacin; Placebos; Receptors, Immunologic; Receptors, Prostaglandin	2009
The effects of laropiprant, a selective prostaglandin D₂ receptor 1 antagonist, on the antiplatelet activity of clopidogrel or aspirin. Platelets, 2011, Volume: 22, Issue:7 Topics: Adolescent; Adult; Aspirin; Bleeding Time; Blood Platelets; Clopidogrel; Female; Humans; Indoles; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Immunologic; Receptors, Prostaglandin; Ticlopidine; Young Adult	2011
The effects of laropiprant on the antiplatelet activity of co-administered clopidogrel and aspirin. Platelets, 2014, Volume: 25, Issue:7 Topics: Adult; Aged; Aspirin; Clopidogrel; Cross-Over Studies; Double-Blind Method; Drug Interactions; Dyslipidemias; Female; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Platelet Aggregation Inhibitors; Ticlopidine; Young Adult	2014